Purpose: Thick choroid (pachychoroid) is associated with central serous chorioretinop-athy (CSC), but whether pachychoroid is inherited is unknown.
Central serous chorioretinopathy (CSC) belongs to this spectrum of diseases associated with enlarged choroid. In 30 patiemts with CSC, choroidal thickness was found significantly increased not only in the affected eye (445.58 ± 100.25) but also in the contralateral unaffected eye (378.35 ± 117.44), and choroid was sig-nificantly larger in the affected eyes.6 In another study, 36 patients with CSC had retrofoveal choroid thickening (459.16 ± 77.50 mm) during the acute phase, regression after spontaneous resolution, and normalization after photodynamic therapy (349.50 ± 88.99 mm).7 Other studies have confirmed that one possible mechanisms of photodynamic therapy in CSC could be related to the reduction of permeability and dilation of choroidal vessels.8-10
However, not all patients with CSC have enlarged choroids, and whether this choroidal vessels dilation is causative of the disease or only a favoring factor remains controversial. The fact that only one eye could ever show serous detachment, whereas both eyes have enlarged choroid, favors consider choroidal thickening as a "susceptibility factor for CSC" rather than as a triggering event.
Sporadic familial cases of CSC have been re-ported11-13 until Weenink et al14 reported that 44% among 80 relatives of 27 patients with CSC had sub-clinical signs of CSC, suggesting a potential autosomal transmission of the disease. Several cases of CSC in two families with anxious profiles have raised the hypothesis that the inheritance could rather be related to specific psychological profile15 rather than CSC inheritance per se. In a larger study including 30 relatives of patients with CSC, signs of CSC were found in 92% of the cases, while no familial history was reported, suggesting that nonsymptomatic forms of the disease could mask inheritance character.16 To date, no clear transmission pattern and no specific genotype have been associated with CSC. One of the difficulties of such genetic studies resides in the identification of a well-defined phenotype. Indeed, with advanced imaging systems, a larger spectrum of clinical entities are being recognized from isolated choroidal enlargement (pachychoroid), pachychoroid pigment epitheliopathy recently described by Warrow et al,17 acute CSC, diffuse retinal epitheliopathy, andage-related macular degeneration-like CSC associated to choroidal neovascularization or pseudo polypoidal vasculopathy, having all in common a thick choroid.
Whether a common physiopathogenic mechanism drives all these clinical manifestations remains to be clarified. Because choroidal thickness is now recognized as a "sign" in the diagnosis of CSC, we have questioned whether choroidal thickness could be a sus-ceptibility inherited factor for CSC. Index, index case in the family.
INHERITANCE OF THICK CHOROID LEHMANN ET

AL
Clinical grade, 0 normal fundus and autofluorescence; 1, focal retinal pigment epithelium hyperfluorescence and/or hypofluorescence and/or retinal pigment epithelial detachment in favor of previous asymptomatic CSR; 2, clinically obvious CSR or diffuse retinal epitheliopathy.
epithelium alterations in at least 1 eye. Exclusion crite-ria were: myopia or hyperopia . 3 diopter (D), ambly-opia, any form of choroidal neovascularization, diabetes mellitus, and hypertension.
All their first-or second-degree relatives (36 individuals) were invited to the clinic for a free ophthalmologic examination. We could examine 16 relatives of the 5 patients. All individuals had refraction and visual acuity measurement, slit-lampand fundus examination, nonmydriatic photography, and a 55° autofluorescence photography (Spectralis; Heidel-berg Engineering, Heidelberg, Germany). We assessed choroid thickness by enhanced depth imaging images performed with 6 linear horizontal scan of 100 averaged images: centered on the fovea, horizontal at 750 mm superior and inferior to the fovea, vertical at 750 mm temporal and nasal from the fovea. Manual measure-ment of choroid thickness was performed by two ophthalmologists (M.L. and E.B.) using caliper place-ment between the hyperreflective band corresponding to the retinal pigment epithelium Bruch layer and the outer hyperreflective band at thesclera-choroid interface. Measures were performed at the fovea, and every 500 mm up to 1,500 mm nasal and temporal from the fovea. Patients were then classified from Grade 0 to 2, using the following criteria: 0: normal fundus and autofluorescence photography; 1: focal retinal pigment epithelium hyperfluorescence and/or hypofluorescence and/or retinal pigment epithelial detachment (in favor of previous asymptomatic CSC); 2: clinically obvious CSC or diffuse retinal epitheliopathy. Figure 1 shows example of this classification.
Results
Subject Characteristics
Twenty-one subjects (5 patients with CSC and 16 relatives), 14 men and 7 women, were included. Mean age was 47 years (14-67 years), 10 of 21 subjects (47.6%) had history of emotional stress or depression, and 11 of 21 (52.3%) had taken corticosteroids by any route in their medical history. History of allergy was recorded in 5 of 21 (24%) of the subjects (Table 2) . There was a significant difference As shown in Table 3 , mean choroidal thickness nasal to the fovea was 319.39 ± 131.85 mm as com-pared with 371.31 ± 108.82 mm temporal to the fovea (P = 0.067), and the mean SFCT was statistically high-er than that the nasal choroidal thickness (319.39 vs. 396.64, P = 0.0065).
Subfoveal Choroidal Thickness as a Potential Inherited Sign, Predisposing to Central Serous Chorioretinopathy
If we consider the SFCT as a screening sign for CSC, we obtain an ROC curve (Figure 3 ) with the best threshold measure at 395 mm, giving a sensitivity of 76.47% and a specificity of 60%. Area under the curve is 0.6894 ± 0.0835 with a confidence interval at 95% from 0.5257 to 0.8532. The mean SFCT of the rela-tives was 375.46 ± 87 mm (vs. 464.4 ± 160.3mm in the patients) with a median of 395.5 mm. When con-sidering 395 mm as the threshold limit for"normal" SFCT, 50%
of the eyes from relatives have an increased SFCT, and among those, 9 eyes (28%) were graded 0. These eyes would have been considered "normal" if choroidal thickness was not included as a screening sign predisposing for CSC. Subfoveal choroidal thickness was measured between 191.5 ± 74.218 and 354 ± 111 mm19 in normal subjects and between 345 ± 127 mm20 and 505 ± 124 mm2patients with CSC, depending on the studies.
In our limited group of subjects, the mean SFCT was 448.1 ± 126.7 mm in eyes with signs of CSC and it was 361.6 ± 89.8 mm in Grade 0 eyes (P = 0.038), which is higher than the SFCT measured in emetropic eyes, suggesting that relatives of patients with CSC may have enlarged choroids. Indeed, the SE (−0.70 ± 1.79) in this group could not explain the larger choroidal thickness.
Other studies evaluating inheritance of CSC have classified eyes depending on their fundus finding: normal fundus, retinal pigment epithelium atrophy and/or pig-ment epithelial detachment, or chronic CSC.14 Eyes pre-senting classic signs of CSC or suspected CSC are thus considered as affected. Taken the same classification criteria, we designed an ROC curve with affected and healthy patients, considering their SFCT as a screening test. The best sensibility was 76.47%, for a specificity of sample (r = 0.53, P = 0.01, Pearson's correlation). 
